Skip to main content
Premium Trial:

Request an Annual Quote

TCA Invests $800K in Coda Genomics

NEW YORK, Oct. 5 (GenomeWeb News) - Coda Genomics has closed an $800,000 Series A round of venture-capital funding, the company said today. 

The Irivine, Calif.-based synthetic biology and protein-expression company gained the funding from an investment by Tech Coast Angels, which provides funding and guidance to early-stage companies based in California.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.